feed,title,long_url,short_url
Benzinga,Galmed Stock Jumps As FDA Signs Off Use Of Aramchol Meglumine In Late Stage NASH Trial,https://benzinga.com/general/biotech/21/08/22273990/galmed-stock-jumps-as-fda-signs-off-use-of-aramchol-meglumine-in-late-stage-nash-trial,https://j.mp/3fmOPyN
